COVID-19 Key EU Developments, Policy & Regulatory Update No. 40

LATEST KEY DEVELOPMENTS Competition & State Aid • Launch of Multilateral Working Group of leading competition authorities to assess the effects of mergers in the pharmaceutical sector, including drug pricing • European Parliament issues Study on Non-performing Loans (“NPLs”), including addressing EU State aid rules and potential surge in NPLs due to COVID-19 crisis • EU approves new and amended Member State measures to support the economy Trade / Export Controls • European Commission...
By: Jones Day

Array